At the Kellogg Cancer Center, we are truly dedicated to improving patient outcomes. We come together as a team of specialty trained physicians, nurses and healthcare professionals, with the most advanced technology and expertise, all working to provide the best possible care to each individual patient.

Kellogg Cancer Center has been designated by Blue Cross Blue Shield of Illinois as a Blue Distinction Center for Complex and Rare Cancers. The Blue Distinction program identifies hospitals with proven expertise in delivering specialty care. These accomplishments validate the team’s approach and underscore the quality, compassionate cancer care patients receive.

From the quickly evolving world of immunotherapy, which we have made a priority and conducted a vast array of clinical trials, to surgical enhancements including robotic pancreatic cancer surgery, we ensure that our patients have access to the latest and most effective therapies.

As both a teaching and research-driven program, we are set apart from many other healthcare institutions. We are further differentiated by our close partnership with the University of Chicago Pritzker School of Medicine and its science faculty. 

In addition, our clinical affiliation with the Mayo Clinic, allows us expedited consultations with Mayo Clinic physicians on particularly complex cases.